Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Patent
1997-06-30
1999-03-09
Dodson, Shelley A.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
623 11, 623 66, A61F 206, A61F 202
Patent
active
058793836
ABSTRACT:
This invention relates to improved blood contact devices such as vascular prostheses rendered antithrombotic through the use of recipient endothelial cells grown on an appropriate subendothelial matrix. The subendothelial matrix layer, which serves as the substratum for growing endothelial cells, may be obtained from either natural donor vessels or from in vitro tissue culture sources. This subendothelial matrix is used in situ on the donor vessel, or is grown or applied to a synthetic component, preferably porous expanded polytetrafluoroethylene. Once this subendothelial matrix is prepared, recipient endothelial cells are seeded onto this matrix substratum, which then serves as the immediate blood contact surface. The endothelial cells may be applied as an intra-operative procedure, or grown on the subendothelial matrix substratum in vitro until the cells establish a confluent monolayer. A key aspect of this invention is that living, recipient endothelial cells are grown on the appropriate subendothelial matrix substratum, thereby providing a substantially nonthrombotic blood contact surface. Furthermore, the likelihood of recipient immunological response is minimized. This invention results in vascular prostheses that are particularly useful for arterial bypass requiring a diameter of 6 mm or less.
REFERENCES:
patent: 3562820 (1971-02-01), Braun
patent: 3953566 (1976-04-01), Gore
patent: 3966401 (1976-06-01), Hancock et al.
patent: 3988782 (1976-11-01), Dardik et al.
patent: 4050893 (1977-09-01), Hancock et al.
patent: 4098571 (1978-07-01), Miyata et al.
patent: 4187390 (1980-02-01), Gore
patent: 4323358 (1982-04-01), Lentz et al.
patent: 4539716 (1985-09-01), Bell
patent: 4546500 (1985-10-01), Bell
patent: 4553974 (1985-11-01), Dewanjee
patent: 4804382 (1989-02-01), Turina et al.
patent: 4883755 (1989-11-01), Carabasi et al.
patent: 4960423 (1990-10-01), Smith
patent: 5037378 (1991-08-01), Muller et al.
patent: 5429938 (1995-07-01), Humes
patent: 5549674 (1996-08-01), Humes et al.
M. B. Herring et al. in "A single technique for seating vascular grafts with autogenous endothelium," Surgery 84:498-504 (1978).
J. Hoch et al. in "In vitro endothlialization of an aldehyde-stabilized native vessel," J. Surg. Res. 44:545-554 (1988).
P. A. Schneider et al., "Confluent durable endothelialization of endarterectomized baboon aorta by early attachment of cultured endothelial cells," J. Vasc. Surg. 11:365-372 (1990).
S.G. Lalka et al., "Acellular vascular matrix: A natural endothelial cell substrate," Ann. Vasc. Surg. 2:108-117 (1989).
L. Bengtsson et al., "Lining of viable and nonviable allogeneic and xenogeneic cardiovascular tissue with cultured human venous endothelium," J. Thorac. Cardiovasc. Surg. 106:434-443 (1993).
J. Hoch et al., "Endothelial cell interactions with native surfaces," Ann. Vasc. Surg. 2:153-159 (1989).
A. Schneider et al., "An improved method of endothelial seeding on small caliber prosthetic vascular grafts coated with natural extracellular matrix," Clin. Mat. 13:51-55 (1993).
Y. S. Lee et al., "Endothelial call seeding onto the extracellular matrix of fibroblasts for the development of a small diameter polyurethane vessel," ASAIO Journal 39:M740-M745 (1993).
Grimm et al., "Glutaraldehyde affects biocompatibility of bioprosthetic heart valves," Surgery 111:74-78 (1992).
H. Miwa et al., "Development of hierarchically structured hybrid vascular graft biomimicking natural arteries," ASAIO Journal 39:M273-77 (1993).
P. Zilla et al., "The endothelium: A key to the future," J. Card. Surg. 8:32-60 (1993).
P. Ortenwall et al., "Seeding of ePTFE carotid interposition in sheep and dogs: species dependent results," Surgery 103:199-205 (1988).
N. L. James et al., "In vivo patency of endothelial cell-lined expanded polytetrafluoroethylene prosthesis in an ovine model," Artif. Org. 16:346-53 (1992).
A. Albini et al., "Fibroblast chemotaxis," Collagen Rel. Res. 5:283-296, (1985).
W. Morzycki et al., "Tumor necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism," Immunology, 74:107-113, (1991).
Begovac Paul Christopher
Bruchman William Carl
Dodson Shelley A.
Johns David J
Sheets Eric J
W. L. Gore & Associates, Inc.
LandOfFree
Blood contact surfaces using endothelium on a subendothelial mat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood contact surfaces using endothelium on a subendothelial mat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood contact surfaces using endothelium on a subendothelial mat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1316102